ingineeon Information

At ingineeon, our mission is to bring breakthrough medical innovations to patients that need them most. To achieve this, we develop advanced cytokine-based immunotherapeutics. Our current pipeline comprises first-in-class biologics in infectious diseases, inflammatory diseases, and oncology. As a spin-off from the Technical University of Munich, our goal is to become a clinical stage company in the coming few years.